Back

Impact of empagliflozin on quality-of-life in real-world patients with heart failure: insights from the multinational Emp-Activity study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Evolving strategies in heart failure management Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Anna Tomaszuk-Kazberuk

Medical University of Bialystok, Bialystok (Poland)

5 More presentations in this session

Presentation thumbnail
Integrated multi-omic response to heart failure reverse remodeling with left ventricular assist device
Doctor X. Xu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Impact of coronary revascularisation in patients undergoing cardiovascular magnetic resonance for viability assessment
Doctor A. Lequipar (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Assessing impact of home-based digital cardiac rehabilitation on readmissions and patient outcomes following step-down from the acute heart failure virtual ward
Doctor D. Duvva (Liverpool, GB) Associate Professor R. Sankaranarayanan (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
The antifibrotic effect of novel heart failure pharmacotherapies in myocardial samples of patients undergoing heart transplantation
Doctor D. Nagy (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
MAGGIC in the machine: unveiling the predictive value of a conventional risk score in the ultra-long LVAD phenotype. Insights from the STELLAR register.
Doctor C. Velasquez-Silva (Bad Oeynhausen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Evolving strategies in heart failure management
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Evolving strategies in heart failure management
thumbnail
Congress Session
Using big data to drive cardiovascular innovations
thumbnail
Congress Session
Strategies for better outcomes in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources